These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11071665)

  • 1. Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation.
    Cilloni D; Carlo-Stella C; Falzetti F; Sammarelli G; Regazzi E; Colla S; Rizzoli V; Aversa F; Martelli MF; Tabilio A
    Blood; 2000 Nov; 96(10):3637-43. PubMed ID: 11071665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engraftment capacity of mesenchymal cells following hematopoietic stem cell transplantation in patients receiving reduced-intensity conditioning regimen.
    Poloni A; Leoni P; Buscemi L; Balducci F; Pasquini R; Masia MC; Viola N; Costantino E; Discepoli G; Corradini P; Tagliabracci A; Olivieri A
    Leukemia; 2006 Feb; 20(2):329-35. PubMed ID: 16341047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human mesenchymal stem cells are not of donor origin in patients with severe aplastic anemia who underwent sex-mismatched allogeneic bone marrow transplant.
    Stute N; Fehse B; Schröder J; Arps S; Adamietz P; Held KR; Zander AR
    J Hematother Stem Cell Res; 2002 Dec; 11(6):977-84. PubMed ID: 12590713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohematologic reconstitution in pediatric patients after T cell-depleted HLA-haploidentical stem cell transplantation for thalassemia.
    Isgrò A; Marziali M; Sodani P; Gaziev J; Erer B; Polchi P; Paciaroni K; Roveda A; De Angelis G; Gallucci C; Alfieri C; Simone MD; Zinno F; Isacchi G; Adorno G; Lanti A; Leti W; Aiuti F; Fraboni D; Andreani M; Lucarelli G
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1557-66. PubMed ID: 20546907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA.
    Mackinnon S; Barnett L; Bourhis JH; Black P; Heller G; O'Reilly RJ
    Blood; 1992 Dec; 80(12):3235-41. PubMed ID: 1467526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Origin of mesenchymal stem cells in bone marrow of patients after allogeneic stem cell transplantation].
    Wang J; Liu KY; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):322-6. PubMed ID: 16638207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engraftment of quiescent progenitors and conversion to full chimerism after nonmyelosuppressive conditioning and hematopoietic cell transplantation in miniature swine.
    Lima B; Gleit ZL; Cameron AM; Germana S; Murphy MC; Consorti R; Chang Q; Down JD; LeGuern C; Sachs DH; Huang CA
    Biol Blood Marrow Transplant; 2003 Sep; 9(9):571-82. PubMed ID: 14506659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation.
    Jiang Z; Adams GB; Hanash AM; Scadden DT; Levy RB
    Biol Blood Marrow Transplant; 2002; 8(11):588-96. PubMed ID: 12463477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced intensity conditioning compared to standard conditioning preserves the in vitro growth capacity of bone marrow stroma, which remains of host origin.
    Spyridonidis A; Küttler T; Wäsch R; Samek E; Waterhouse M; Behringer D; Bertz H; Finke J
    Stem Cells Dev; 2005 Apr; 14(2):213-22. PubMed ID: 15910248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor immune reconstitution after four or five major HLA antigens mismatched T cell-depleted allogeneic and autologous stem cell transplantation.
    Mattsson J; Uzunel M; Remberger M; Tammik L; Omazic B; Levitsky V; Zou JZ; Hentschke P; Ringdén O
    Clin Exp Immunol; 2001 Jan; 123(1):162-9. PubMed ID: 11168014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
    Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C
    Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy.
    Wu T; Sozen H; Luo B; Heuss N; Kalscheuer H; Lan P; Sutherland DE; Hering BJ; Guo Z
    Bone Marrow Transplant; 2002 Jun; 29(12):949-56. PubMed ID: 12098061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation.
    Fehse B; Chukhlovin A; Kühlcke K; Marinetz O; Vorwig O; Renges H; Krüger W; Zabelina T; Dudina O; Finckenstein FG; Kröger N; Kabisch H; Hochhaus A; Zander AR
    J Hematother Stem Cell Res; 2001 Jun; 10(3):419-25. PubMed ID: 11454317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients.
    Galotto M; Berisso G; Delfino L; Podesta M; Ottaggio L; Dallorso S; Dufour C; Ferrara GB; Abbondandolo A; Dini G; Bacigalupo A; Cancedda R; Quarto R
    Exp Hematol; 1999 Sep; 27(9):1460-6. PubMed ID: 10480437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of adult marrow-derived stem cells to generate marrow stroma after successful hematopoietic stem cell transplantation.
    Awaya N; Rupert K; Bryant E; Torok-Storb B
    Exp Hematol; 2002 Aug; 30(8):937-42. PubMed ID: 12160845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum.
    Aversa F; Tabilio A; Terenzi A; Velardi A; Falzetti F; Giannoni C; Iacucci R; Zei T; Martelli MP; Gambelunghe C
    Blood; 1994 Dec; 84(11):3948-55. PubMed ID: 7524753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation.
    Antin JH; Childs R; Filipovich AH; Giralt S; Mackinnon S; Spitzer T; Weisdorf D
    Biol Blood Marrow Transplant; 2001; 7(9):473-85. PubMed ID: 11669214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.